Marshall Financial Group (Maryland)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-427
Closed -$223K 174
2023
Q2
$223K Sell
427
-47
-10% -$25.4K 0.08% 163
2023
Q1
$273K Sell
474
-1,462
-76% -$824K 0.1% 154
2022
Q4
$1.07M Buy
1,936
+163
+9% +$86.4K 0.41% 78
2022
Q3
$899K Sell
1,773
-40
-2% -$22.4K 0.38% 75
2022
Q2
$985K Buy
1,813
+1,397
+336% +$769K 0.39% 70
2022
Q1
$246K Sell
416
-50
-11% -$28.7K 0.1% 187
2021
Q4
$311K Buy
+466
New +$291K 0.11% 176

Other funds holding TMO

Marshall Financial Group (Maryland)'s TMO Position: Q3 2023 in Review

Marshall Financial Group (Maryland) sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 427 shares — an estimated $223K sold.

Marshall Financial Group (Maryland) first reported a position in TMO in Q4 2021 and held it in 7 quarters. The position peaked at $1.07M in Q4 2022. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Marshall Financial Group (Maryland) reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Marshall Financial Group (Maryland) sold 427 Thermo Fisher Scientific shares in Q3 2023, an estimated $223K.
  • Marshall Financial Group (Maryland) first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 7 quarters.
  • Marshall Financial Group (Maryland)'s Thermo Fisher Scientific position peaked at $1.07M in Q4 2022.
  • 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Marshall Financial Group (Maryland)'s 13F filing for Q3 2023, filed 19 Oct 2023.